What Krystal Biotech, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 34 | 142 |
| Total trades | 35 | 174 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 212,845 |
| Disposed | 78,691 | 459,917 |
| Net activity | −78,691 | −247,072 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −405 | $366.56 | −$148K | 1,347,543 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −847 | $365.42 | −$310K | 1,347,948 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −1,358 | $364.48 | −$495K | 1,348,795 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −573 | $363.34 | −$208K | 1,350,153 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −2,010 | $362.65 | −$729K | 1,350,726 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −1,214 | $361.61 | −$439K | 1,352,736 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −2,266 | $360.46 | −$817K | 1,353,950 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −3,357 | $359.39 | −$1.21M | 1,356,216 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −3,143 | $358.42 | −$1.13M | 1,359,573 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −3,981 | $357.57 | −$1.42M | 1,362,716 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −3,297 | $356.37 | −$1.17M | 1,366,697 |
| Krishnan Krish S | President and CEO | Sep 04 | Open-market sale · S | −2,029 | $355.57 | −$721K | 1,369,994 |
| Krishnan Krish S | President and CEO | Sep 04 | Disclosed 10b5-1 sale · S | −520 | $354.54 | −$184K | 1,372,023 |
| Krishnan Suma | President, R&D | Sep 04 | Open-market sale · S | −399 | $366.56 | −$146K | 1,302,145 |
| Krishnan Suma | President, R&D | Sep 04 | Open-market sale · S | −826 | $365.41 | −$302K | 1,302,544 |
| Krishnan Suma | President, R&D | Sep 04 | Open-market sale · S | −1,329 | $364.48 | −$484K | 1,303,370 |
| Krishnan Suma | President, R&D | Sep 04 | Open-market sale · S | −565 | $363.34 | −$205K | 1,304,699 |
| Krishnan Suma | President, R&D | Sep 04 | Open-market sale · S | −1,992 | $362.65 | −$722K | 1,305,264 |
| Krishnan Suma | President, R&D | Sep 04 | Open-market sale · S | −1,242 | $361.61 | −$449K | 1,307,256 |
| Krishnan Suma | President, R&D | Sep 04 | Open-market sale · S | −2,320 | $360.47 | −$836K | 1,308,498 |
Loading...
